• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TAEWOONG MEDICAL CO.,LTD. NITI-S BILIARY SUPREMO STENT; BILIARY STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TAEWOONG MEDICAL CO.,LTD. NITI-S BILIARY SUPREMO STENT; BILIARY STENT Back to Search Results
Model Number BSD1008FW
Device Problem Insufficient Information (3190)
Patient Problem Stenosis (2263)
Event Date 11/13/2020
Event Type  Injury  
Manufacturer Narrative
It was reported that about 1 years after the stent placement, re-obstruction was confirmed at the stent placed part.It is hard to review suspected device's dhr, because the serial no was not checked.Biliary structure where stent was implanted is narrow and curvy.It is possible that the stent could be pressed by state of patient's lesion.However, it is hard to identify the exact root cause since it is hard to reconstruct the situation at the time of procedure.It is hard to identify the exact cause since it is hard to reconstruct the situation at the time of procedure and the device was not returned and the information such as photo was not provided.However, based on the description, "re-obstruction might be caused by the increase of malignant tumor through the mesh." it is assumed that the stent was pressed due to the strong pressure of the patient lesion and progress of disease, resulting in re-obstruction.Through the user manual by taewoong, it is stated that, "potential complications associated with the use of niti-s & comvi stent may include, but are not limited to: bile duct obstruction." this suspected device is not registered in the us but we will continuously monitor the same or similar customer complaints through accurate analyses.
 
Event Description
Bsd1008fw (s/n: unknown) was placed for the malignant stenosis in mid-lower bile duct about one year ago.On (b)(6) 2020, re-obstruction was confirmed at the stent placed part.Therefore, the physician placed another stent in stent-in-stent method.Re-obstruction might be caused by the increase of malignant tumor through the mesh.There were no patient complications as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NITI-S BILIARY SUPREMO STENT
Type of Device
BILIARY STENT
Manufacturer (Section D)
TAEWOONG MEDICAL CO.,LTD.
14, gojeong-ro
wolgot-myeon
gimpo-si, gyeonggi-do 10022
KS  10022
Manufacturer (Section G)
TAEWOONG MEDICAL CO.,LTD.
14, gojeong-ro
wolgot-myeon
gimpo-si, gyeonggi-do 10022
KS   10022
Manufacturer Contact
lee
14, gojeong-ro
wolgot-myeon
gimpo-si, gyeonggi-do 10022
MDR Report Key11000880
MDR Text Key221241295
Report Number3003902943-2020-00101
Device Sequence Number1
Product Code FGE
Combination Product (y/n)Y
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 11/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/14/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberBSD1008FW
Was Device Available for Evaluation? No
Date Manufacturer Received11/18/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-